Biliary cystadenocarcinoma with superficial spread to the extrahepatic bile duct.
Joe Matsumoto(Hokkaido University), Mitsuru Fujita, Yoshiyasu Ambo(Hokkaido University of Science), Seishiro Hirano(National Institute for Environmental Studies), Hiroyuki Katoh(Hokkaido University Hospital), Tatsuya Morikawa, Satoshi Kondo(Hokkaido University), Hiroshi Sugiura, Omi A, S Okushiba
PubMed
January 16, 2002
Cited by 8
Related Papers
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749
A new metabolic pathway of arsenite: arsenic?glutathione complexes are substrates for human arsenic methyltransferase Cyt19
|Archives of Toxicology|2004|530
Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus
|World Journal of Surgery|1990|506
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Metabolism of arsenic and its toxicological relevance
|Archives of Toxicology|2012|328